# Therapeutic Cocaine Vaccine: Human Laboratory Study

> **NCT00965263** · PHASE2 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 15 (actual)

## Conditions studied

- Cocaine Dependence

## Interventions

- **BIOLOGICAL:** Cocaine vaccine (TA-CD)

## Key facts

- **NCT ID:** NCT00965263
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-03
- **Primary completion:** 2009-07
- **Final completion:** 2009-08
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00965263

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00965263, "Therapeutic Cocaine Vaccine: Human Laboratory Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00965263. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*